Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/8/17 → 8/31/50 |
Funding
- Aimmune Therapeutics, Inc.
ARC-008: A Multicenter, Open-label, Long-term Safety Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects who Participated in a Prior AR101 Study
- Makhija, Melanie Mala (PD/PI)
- Pongracic, Jacqueline A (Co-Investigator)
- Robison, Rachel G (Co-Investigator)
Project: Research project